Grifols (MEX:GRFP N) Construction In Progress: MXN0 Mil (As of Mar. 2026)


MEX:GRFP N Grifols SA MEX:GRFP N
83 GF Score
Price MXN126.63
GF Value MXN154.24
! 6 Warning Signs
View Full Analysis

What is Grifols Construction In Progress?

Grifols MEX:GRFP N 83 Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:GRFP N with a GF Score™ of 83/100 and a GF Value™ of MXN154.24. The stock has 6 warning signs investors should review.

Grifols's quarterly construction in progress increased from Sep. 2025 (MXN0 Mil) to Dec. 2025 (MXN15,307 Mil) but then declined from Dec. 2025 (MXN15,307 Mil) to Mar. 2026 (MXN0 Mil).

Grifols's annual construction in progress increased from Dec. 2023 (MXN16,857 Mil) to Dec. 2024 (MXN17,514 Mil) but then declined from Dec. 2024 (MXN17,514 Mil) to Dec. 2025 (MXN15,307 Mil).

Grifols Construction In Progress Historical Data

* Premium members only.

The historical data trend for Grifols's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grifols Construction In Progress Chart

Grifols Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,704.32 0.00 16,857.08 17,514.42 15,306.95

Grifols Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 15,306.95 0.00
MEX:GRFP N
83GF Score
Grifols SA MEX:GRFP N
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grifols Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN0 Mil mean?
Grifols (MEX:GRFP N) has a Construction In Progress of MXN0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Grifols and its competitors.
Is Grifols' Construction In Progress too high?
Grifols' current Construction In Progress is MXN0 Mil. Overall, Grifols has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' Construction In Progress compare to LLY and JNJ?
Grifols' Construction In Progress of MXN0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Grifols and its competitors. Grifols's current Construction In Progress is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (MEX:GRFP N) has a current Construction In Progress of MXN0 Mil. The stock's GF Value™ is MXN154.24, compared to a current price of MXN126.63 — trading 17.9% below its estimated fair value. The current Construction In Progress is MXN0 Mil. Grifols' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Grifols (MEX:GRFP N), the current Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grifols (MEX:GRFP N) Overvalued in 2026?

Based on GuruFocus' analysis, Grifols stock appears to be undervalued. The current stock price of MXN126.63 is trading 17.9% below its estimated GF Value™ of MXN154.24.

Key valuation signals for MEX:GRFP N:

  • Construction In Progress: MXN0 Mil
  • GF Value™: MXN154.24 vs. price of MXN126.63 (17.9% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the MEX:GRFP N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grifols Business Description

Address Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
83GF Score

Get the complete analysis for MEX:GRFP N

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN126.63
Price
MXN154.24
GF Value